Company Data

HilleVax Inc.

Ticker
HLVX
Current Price
$1.83 -2.14%
Market Cap
$91.1M
Price Target
Refer to Report
Volume
89.4K
52wk Range
$1.55 - $20.22
Advanced Market Data

Overview

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm’s initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy